[{"title": "US FDA approves Precigen's immunotherapy for rare respiratory disease - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNa0ZEMEppdGt5bFdsb0FEZUNHZmIwcXpNa3BvMmprVFZBaHNsWDZrTFd2R0VNVEJyRl9MczZ5QjhiNmZ5TnpQX29DR0Y2Qk0tWlBSd1JKTkdjMllsNmRFYXVvSzRwdk96dzVpZlRUVmRNb1lWR280RWNXcU1JNWxmR3pGbVZjUTN3QVVra1ppX195MlVWTHdCMVBiY0Vzc0dvenE0X2Mza25ILURXMnE5RmtCQ2pIeU52cGhhY2hGUllROUZERGUwYnNVakQ3alRMaGc?oc=5\" target=\"_blank\">US FDA approves Precigen's immunotherapy for rare respiratory disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 14:01:40 GMT"}, {"title": "Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos - Quiver Quantitative", "description": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNbVFqYkN5VTdGSkVsYzZVUU44dUdTbFR6bUs1TUFSVk4tRG1DT2xWc3U2a3VxYXFEMkdocDZKN19lV0Zla0pOampSR05WQU1vTDlYYmJCdjJLMW1sSTk2aDJqWWllTkxsbjRaY0UxNFAwUFpqUmd4dDR3WklrTk9Pa3gxNXRTVUs0UGRHUF81bDRNdHFXeGxaZWdIS2g2R0p4eGJMZXhRNA?oc=5\" target=\"_blank\">Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>", "publishedAt": "Fri, 15 Aug 2025 17:32:00 GMT"}, {"title": "Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMi2gJBVV95cUxOdndORDBKcUpBa2ZUR04zT0E4NWs0eWRaRkFhM3Naek1GZ1pQbTUyX3d2akFlU2xmdTlvMVFKQWRnRGhZeUt5MGJhMjVXZGY3T2Z2MlVfQk5MaF9vd2FiVENWRHYtSzZIYUctWHVuZXo4LUE5c0Z2cHdjZFpfVy0yOEZTR0I4aEFZdGZfWEw3UEJJbXBaYTFmdVkxVTJ4SnBIbGh1SkFBOXpBMTdkNlNONXA0WkRMbUYzVTJjclAyeUhnck1jbE5KRFFUMWc5S1lwOUNCSVBKa0FMNVcxUmNsYTRSczI5OUh5Q0Q2bG5GR2xHb09lNXhpRGF6cEstN2tZb3lnd01rbVZyMWtFdkZUSWxUcFdoV0RCeUJtYUNObHpzSjFGRUdOU0ZWSHdjal9hNzNFRk5LZ2VRX2Q1eVVyMF9YbWo2OGIzVU5kTVJCSGp3ajU4OTZVOWZR?oc=5\" target=\"_blank\">Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>", "publishedAt": "Fri, 15 Aug 2025 11:00:00 GMT"}, {"title": "Precigen, Inc. Reports Q2 2025 Earnings and Strategic Focus - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQVkExNkZfdGVWUlA2dXQ0OFBENWIyc0gyX2RyT2N0ZlFRZHRQYklrNy1fb3pMVFlkNGhNa3JjRnpEcHk2RWpyRVpRTnFvN0k0OUJzTG9oNDd0dHNPN2xrZ1JwdHZPeXJNWUVGR05xMl9UT0tibmR5dW5zVTFpeHZVZmJGMUFlNjJiZUFWdVJtSzZmVnZTREo1MEVSRk9OUHlhcjlPQ0R2R2lHYmpiZ1E?oc=5\" target=\"_blank\">Precigen, Inc. Reports Q2 2025 Earnings and Strategic Focus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Wed, 13 Aug 2025 04:09:06 GMT"}, {"title": "Precigen stock surges on FDA approval (update) (PGEN:NASDAQ) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObjZYcU1aYVhpOTJtZnEtT3d5NW5sb2VSbGZZck54VlA2UmNZVVdlR1I3eko3MVA2ZmRhaGZpX3k2TkpGb0Zwb3loWGNMTUxKZkk5ZVAwV05UMmdkSWdnYzk2bmw1X3drUU5GOVFyTWVFOVZzaGdPMTNwbEZIRHZtRlJR?oc=5\" target=\"_blank\">Precigen stock surges on FDA approval (update) (PGEN:NASDAQ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Fri, 15 Aug 2025 11:21:00 GMT"}, {"title": "Precigen\u2019s Remarkable Uptick: What Drives It? - StocksToTrade", "description": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE41UWVjbHVFSFh3ak1yUGRWQWs0aHhJUGw0T1k4MGNNNFhfX05yeG5OVlBtYXlKQkFWUlMzZHJkUHVWUHVfb0VTQzR2N0VMLVp4WHVPTXZIcnpZNkhsa1VYcjRadDVORFAxejduaGhEdWFnX00?oc=5\" target=\"_blank\">Precigen\u2019s Remarkable Uptick: What Drives It?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">StocksToTrade</font>", "publishedAt": "Fri, 15 Aug 2025 14:04:00 GMT"}, {"title": "Precigen stock soars after FDA approves first RRP treatment - Investing.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNa3AwbkNxT0pjOV9ETnZMbEI5NzFmUU1SMHlZdS1fMnlmcFlCRWtPU1lKWkxMYVo3Q2Mxa3hNT2I0Ri1YaWpvSno5UHlRZ2ZpTUZ5Z05HbWFqYl91V25xYXg5Y1RNYlRaVFRnVlZaUVlQVVB0SjBIOVR2amVIcWV6a09TSkw1RUh1TDV4QUtDaG1vNWF3OWxlbTNsRFJMUXZ4MG9LMWJ0alhrNkxsd29kcHlPbWs2OE9ZWV81TlhR?oc=5\" target=\"_blank\">Precigen stock soars after FDA approves first RRP treatment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>", "publishedAt": "Fri, 15 Aug 2025 15:09:01 GMT"}, {"title": "Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQLUxieEctQ0xPenBER2tpMWZVOFdMVnRYTFliU3pWZGJwZVpvdUxHWVlJbmV3b1VIYi1ld3UwZ2R3RHFFZ2ZDd1I4Wko4ZjZncldqZ0Z3eXRQWEJGVFNlQk12VzRKMWRKNzZsaHFjcXlid1RYZlFGQUIweGRuLVlyQmg5dnF0MnJlQnZXUmRwTWVqcFFzMWh5SGQ5OW9TVi1wanVUTERiSG9jOFI2TzFBQ1VfYl9TU0V1b3dXZ242N1BRSC1yUVBEbUFzWFlWaDFzZDQwSGRwWk8ydTRRa2c?oc=5\" target=\"_blank\">Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Fri, 15 Aug 2025 14:14:01 GMT"}, {"title": "A speedy FDA approval for Precigen\u2019s rare disease gene therapy - BioWorld MedTech", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNSEwzTVpzZDZuOVZRNGRRYk9wVi1GV1BpUVNLZ1Q0S25MUEVzMUZ5NU84MUxtT1hBcHExU0xRN3ExWHBnd21ZR0lpRWYtbThGU3Z6UUx2Yjg0cGdXeVZYbTR6dWRtMUk5ZmxLaFltM2cxVGtmbmtvVG5ER2lNcTE5N0xlSFBDWTVLczVoaW1RYjlnOVFPV3NMT3VhSHA0eGx1Sm5vWg?oc=5\" target=\"_blank\">A speedy FDA approval for Precigen\u2019s rare disease gene therapy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioWorld MedTech</font>", "publishedAt": "Fri, 15 Aug 2025 15:00:00 GMT"}, {"title": "FDA Fully Approves Precigen\u2019s Papzimeos - Contract Pharma", "description": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxOaEZ6U2dsekZUMENTZGpjcmd0a0ltblFMNDY5TnpJQ0ZLQVR3MDRPWGlfSFNCcmJqWmJ3VC1LeGZIRjRNWmRTRzgtc3RfVEp0amFNc2ZCMXJLdUYzTnFteElzMGRwUjUwMW83b0JzeXZRUFkySnFIeDNWeE5aZEdBOHJTeERvRlZjM1cxaQ?oc=5\" target=\"_blank\">FDA Fully Approves Precigen\u2019s Papzimeos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Contract Pharma</font>", "publishedAt": "Fri, 15 Aug 2025 13:13:38 GMT"}, {"title": "Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co. - GuruFocus", "description": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxQX1lOT1lFeU83NjBmeVFhYWtiTHVxejA1X3pGWVA0a2RyWHlUa01nc3hiakVlOG1WVGtoNXNvSjA5dGlrMmlmdkpLODNpa1BfUUE3dlMxbXZtVk1STkU5aVdIVnp3ZWtWUWdhQWxzeGxKS19BbzF2RDVMU3ltQVRLRzBNeHJEczBYeDU4VHFKNU1qdGtXVWwwM2ZSeXNPV3hpRE1sT1B1TFNMYXBpVHowN09adWU?oc=5\" target=\"_blank\">Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>", "publishedAt": "Wed, 13 Aug 2025 12:31:27 GMT"}, {"title": "Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why - Stocktwits", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxOc25aZ1dLTmd4U2tDcTdPNHlTb1lmOWZpeFVQVlM2aVhrcFVmS0ZrRVlKTmRITElnQjF2MFlrOU1nakFvdnkzUVdqUHFSSHdLX3lzcVg3amt3QUl5TlVkQ2VtSWg4b1VjcXBJWkVoeU5GdDlUcGpKcXJWeWpvaDRSUWtEYi1JZHJjOUFPZ2tuZFYtbzlCU0JsaWt3TE5PUm5KSzVkdnNMUFFTVWdkT0stSXdGa1ZhVHAySndadEpR?oc=5\" target=\"_blank\">Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocktwits</font>", "publishedAt": "Fri, 15 Aug 2025 12:01:00 GMT"}, {"title": "Precigen shares jump after US FDA approves first therapy for rare respiratory disease - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOb1NLR212RlJKakJ4cEVTTTRHNTR6OFB6cXU2NC0yYzdrV05IZVdCY29NR0xySm9CTVpZd21tYS01T3pHRnN6YXJUMUpKa2JyYktEa3hKQkxKUTI0ZDhUdGc0T01mbV9sb19pM2R4Qnkzc3dzMWtjRXJSeVFNcUJwOGxGZXZCcmZXRTVvamlUWVpHUl9xRk1sd2loQnpoRmI4UFpQNGM4Tk1iMHBiQ0pEVlNaeUxQMjVUS0dzU09JMC1vU0diYUQxU05Zd3BMMVZfNFhGdk1CNTdHMG43ZFE?oc=5\" target=\"_blank\">Precigen shares jump after US FDA approves first therapy for rare respiratory disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 15:34:49 GMT"}, {"title": "Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPWnp2NHdLN0VMZk1Ucmg2RThLd1pkT05WTW1JS0cydlVnandkYzZhVG1xOS1jcFUyajVhakhGVUh0LWk5V2tZWW5tc3pJWGIwaHJSUXdLRjdtdXJYeVp5d0p2LWdDbmZEajM2cVhKUXpXeUU3V1Z6dEJ3RzlNNjc3bjhMUXN1cFpjU3U0Y0VGYUprRzZaeFZrTTN1ay1Hbktp?oc=5\" target=\"_blank\">Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Fri, 15 Aug 2025 19:15:01 GMT"}, {"title": "Why Is Precigen Stock Surging On Friday? - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOTFIwUmQ4RElvczAySGMzMDRDaTJqdjVWdExURkJjc05Idms4ME1PcWJSb3JoUUpEUzUxcW5MTHZuZWtqc0xWSTN0cXBza2MxRERIX3ZLTWlqYm1IRzRMZ2hDMTJjalk5R0p3R3VwY2pHOWtodmd3NjZfOEhYdWN3MjdjZ3BURW5JVFpPOFh5VWFSZw?oc=5\" target=\"_blank\">Why Is Precigen Stock Surging On Friday?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Fri, 15 Aug 2025 13:48:12 GMT"}, {"title": "FDA approves Precigen immunotherapy for respiratory papillomatosis - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNa1QzRzE1Q3dtakwtUnlzWFpuTTJXTUpRRm9XN1VPcjRMb0M2bzlObVlQLS1SYjBNVm9keTRKMVI3QUl5ZVVwMk8yYTNtTzhCMDNXRVVoMjR5c2NXaHd0Ulc1aGlJNmY0RWlIMUlkc3V3cTYwU1RJRF9zVlBuSVNGa0o3bTFNMGNTdVc0TGR1ZjA3bmd4UFVfRFRGMDdka1Y1clphRkJHd1NwSHdtOC1pTw?oc=5\" target=\"_blank\">FDA approves Precigen immunotherapy for respiratory papillomatosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Fri, 15 Aug 2025 09:08:43 GMT"}, {"title": "Precigen upgraded to Neutral from Underweight at JPMorgan - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxPdEdEbUJ6ZGlvN2FwVVFzSzUzLTd4RDMxb1Vpb0MyRWpySHdRT0xfdDh0dTRaUGxWX2lWTHNEeklWV2hSTUc4NkhGSEc0bTJlUUtPT2ZoajNfT0YwMTBTLTlGQm5iN0RaaVg4bnVNQnRUbllvRGsxa2FqZHZ0ci0tRWUwdVdmRjBXbDNuSXlwT1MzNUx1TGo1SG1hTjJrekV6a2FzcA?oc=5\" target=\"_blank\">Precigen upgraded to Neutral from Underweight at JPMorgan</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Fri, 15 Aug 2025 11:06:15 GMT"}, {"title": "HC Wainwright Adjusts Price Target on Precigen to $8.50 From $6, Maintains Buy Rating - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOQmxqb2VVNGtRRzYwQ1kzTnA4Yk1JNFBzeDFhSW41N003NHU4ZUtEc3FrYlEyYV83YTY1TURZNUJmRWJGTXdJTHhYNS1ncTZHai1PN0NWbjhSdWNXaExOSVMxNWs5SUVEZEo4d3NBUExNcy1TUnY3ZWpXV0ppOGdQb3hKRmtCRGZBc0FiZl9sWHlGN1ljWnBRMGVGbThvdUJXUC1rSlpCRVQ3eUpGYmFoYnA3SGNlblFiMkFsOVpKdlZCakQzTkJjUmt1RnE3dG5h?oc=5\" target=\"_blank\">HC Wainwright Adjusts Price Target on Precigen to $8.50 From $6, Maintains Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Fri, 15 Aug 2025 12:13:43 GMT"}, {"title": "JPMorgan Upgrades Precigen to Neutral From Underweight - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPOFJvUjQ3ZFZDZkk2ZmpXb01Zb2lRMWxzeTVSQlRYRHE5UDB1VENWU3Y0WVdBS0IwR0U1aUlUNGdzLWNUdDNwVHdhU2VHM29QMFNIWndpU1I4RVllemdRMndaUklGLTBRUWdtVW5ZQ2pTdWFMSEgwc0xpWk5LT1VuZlpBOG1UNHh6RkF3RFdZbW1yenNFOG5JRGZOLXo0T3djY29Fdm5uRWYtODA?oc=5\" target=\"_blank\">JPMorgan Upgrades Precigen to Neutral From Underweight</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Fri, 15 Aug 2025 11:33:06 GMT"}, {"title": "Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why By Stocktwits - Investing.com India", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbkdjRHpGMVY1WFJDRUZZMEtMTGoxZl84ZUc5d1JHZmh5ZGdMSEtRdUFCa3VVTzRYYm43d244OUwyREFMNGZxLWpaZVdNNVUyRWNDU0I5THF4QnluZHpoLURud21YZTJ2YUV0N1hjMGhtNUxhVF92ZVBXRkgyVk9rLVNHZWg3LVVzeWRKYVg3RDhHTl9iUVRGYUVURDVwRWMyODMtVF9wZEpQNktRRHo1YzhPX1BfV1p1ZlotaG1R?oc=5\" target=\"_blank\">Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why By Stocktwits</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com India</font>", "publishedAt": "Fri, 15 Aug 2025 11:58:13 GMT"}, {"title": "How to recover losses in Precigen Inc. stock - July 2025 Fed Impact & AI Based Buy and Sell Signals - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxQR0hXNjFJU3FMMXdaRVdwVFlITlpLLU4wSmpxRWIzT05Hb3d1WnRQc3l6VldMQUZoSGExX2txcnprTktuWXZWaHNMdWZ0X3h1dTNaSW41R0p1ckc0YjdGVmZuUS16TlgtRDVNWjhDVWM0RUVGcEs1OEJLUG10ZjNVYw?oc=5\" target=\"_blank\">How to recover losses in Precigen Inc. stock - July 2025 Fed Impact & AI Based Buy and Sell Signals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 13:00:44 GMT"}, {"title": "How to manage a losing position in Precigen Inc. - Earnings Recap Report & Daily Growth Stock Tips - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxOVXpadEZrWk5vNVh2M21BcVdPQjBnUl9VbFhUWWgtMmlJd2N5b0NyX3Vza2c1Y1d2NXZtR3NOVjRmZzR0UGNIZlhCbFlycXpKNFNPVGROaUM4Q0NEZU84Mkx2bkF4LWZCOEZkRnl1UDdjSHQ2emFHaVBwbWYtSXByc2F1YmFJWXl6VXc?oc=5\" target=\"_blank\">How to manage a losing position in Precigen Inc. - Earnings Recap Report & Daily Growth Stock Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 10:06:17 GMT"}, {"title": "Short interest data insights for Precigen Inc. - Portfolio Gains Summary & Expert Approved Momentum Ideas - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOZUxLQ21FVkN2QUZLRlN5Tnd4VjdpcFdHR0dKZVFkVDBLR2tkZUI3aWtyZlgxM3hVb0RrTkxILW0yLUlyZmdId1BMRElQaXBVLVlZbTlfdmw4UXcyRG9RZEVGX2dKVDgxem1wU1hJZ2NSbzVFR0FCZnlWbG9kY1NSaFdR?oc=5\" target=\"_blank\">Short interest data insights for Precigen Inc. - Portfolio Gains Summary & Expert Approved Momentum Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Thu, 14 Aug 2025 08:24:54 GMT"}, {"title": "Has Precigen Inc. found a price floor - July 2025 Rallies & Intraday High Probability Alerts - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTE8taG5qQnFYVGVNSHdVQUhSanVUaEtsbnV4ZHlELUVMQXZFZEwtZGJlQ3Jua3Q4Z281TVhZckg1b3I4X1NYRy1UYmlnWVM1STYtd0JlOEhzR2VfTHZWLXZoamJMalVFX1FIUHhSVE1rbVBDMVRzODBaZER3?oc=5\" target=\"_blank\">Has Precigen Inc. found a price floor - July 2025 Rallies & Intraday High Probability Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Thu, 14 Aug 2025 08:32:05 GMT"}]